Ward Shane
COO & CLO
Ward Shane has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 7, 2026.
On the most recent filing, Ward Shane is listed as COO & CLO at Cidara Therapeutics, Inc. Inside the rolling window, Ward Shane reported no open-market purchases and 1 open-market sale totaling $2.2M in CDTX.
Companies traded
Other insiders at CDTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ward Shane made?
Ward Shane has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Ward Shane trade?
Ward Shane has filed SEC Form 4 disclosures for 1 company, including CDTX.
When was Ward Shane's most recent SEC Form 4 filing?
Ward Shane's most recent SEC Form 4 filing on Tracefour is dated Jan 7, 2026.
What is Ward Shane's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ward Shane is listed as COO & CLO.
What is Ward Shane's total buy and sell value in the current window?
Inside the rolling retention window, Ward Shane bought $0 and sold $2.2M based on SEC Form 4 filings.
What was Ward Shane's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,959 CDTX shares on 2025-12-10, worth $2.2M, per SEC Form 4 filings.